A randomised trial of secondary prophylaxis using granulocyte colony-stimulating factor (‘SPROG’ trial) for maintaining dose intensity of standard adjuvant chemotherapy for breast cancer by the Anglo-Celtic Cooperative Group and NCRN

Autor: A. Yellowlees, K. Benstead, Stephen Chan, Robert C. F. Leonard, R. Matthew, D. Adamson, S M Crawford, R. Grieve, Janine Mansi, Catriona Keerie

Publikováno v: Annals of Oncology. 26:2437-2441

Guidelines on the use of haematopoietic colony-stimulating factors for patients having adjuvant chemotherapy for breast cancer are designed to minimise the risk of neutropaenic infection (Smith TJ, Khatcheressian J, Lyman GH et al. Update of recommen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a8a30d30e88da115c49f65a91f94386
https://doi.org/10.1093/annonc/mdv389

A WIYN NEAR-INFRARED INVESTIGATION OF THREE MASSIVE STAR-FORMING REGIONS

Autor: Ed Churchwell, S. M. Crawford, Remy Indebetouw, Kathryn E. Devine, C. Watson

Publikováno v: The Astronomical Journal. 135:2095-2107

We investigate three embedded massive star-forming regions using the Near-Infrared Imager (NIRIM) camera on the 3.5 m WIYN telescope. We report J-, H-, and K'-band photometry in the clusters AFGL437, AFGL5180, and AFGL5142, and use these results to p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb23235bc5a468dad1286048a0b01cd7
https://doi.org/10.1088/0004-6256/135/6/2095

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials

Autor: R.K. Agrawal, R Cf Leonard, Elena Provenzano, Peter Simmonds, Sarah Jordan, S M Crawford, Robert Grieve, S. Bathers, David Cameron, Carlos Caldas, J Ms Bartlett, Fiona M. Blows, D.W. Rea, Louise Hiller, I. N. Fernando, Karen McAdam, Sarah Bowden, P Pharoah, Janine Mansi, Helena M. Earl, David Spooner, Janet A. Dunn, Alison F. Munro, Andrew Stanley, L. Foster, Chris J. Twelves, S O'Reilly, Christopher J. Poole, A.M. Brunt, A-L Vallier

Publikováno v: British Journal of Cancer
Earl, H M, Hiller, L, Dunn, J A, Vallier, A-L, Bowden, S J, Jordan, S D, Blows, F, Munro, A, Bathers, S, Grieve, R, Spooner, D A, Agrawal, R, Fernando, I, Brunt, A M, O'Reilly, S M, Crawford, S M, Rea, D W, Simmonds, P, Mansi, J L, Stanley, A, McAdam, K, Foster, L, Leonard, R C F, Twelves, C J, Cameron, D, Bartlett, J M S, Pharoah, P, Provenzano, E, Caldas, C, Poole, C J 2012, ' Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised phase III NEAT/BR9601 trials ', British Journal of Cancer, vol. 107, no. 8, pp. 1257-1267 . https://doi.org/10.1038/bjc.2012.370

Background:\ud The National Epirubicin Adjuvant Trial (NEAT) and BR9601 trials tested the benefit of epirubicin when added to cyclophosphamide, methotrexate and 5-fluorouracil (E-CMF) compared with standard CMF in adjuvant chemotherapy for women with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00a1b6ab9c6c1ed53cf274faa0f92266
https://eprints.keele.ac.uk/3177/1/bjc2012370a.pdf

Lung cancer referral patterns in the former Yorkshire region of the UK

Autor: C. E. Round, M D Peake, P.P. Melling, A C Hatfield, M F Muers, R A Haward, S M Crawford, C J Storer

Publikováno v: British Journal of Cancer

The purpose of this study was to find out what proportion of patients are referred as lung cancer guidelines assume, whether different referral pathways result in different management and what proportion of patients are seen within recommended time i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d1221a7d41cff5e0718780c1091077f
https://doi.org/10.1038/sj.bjc.6600029

Mature results of a randomized trial of two doses of cisplatin for the treatment of ovarian cancer. Scottish Gynecology Cancer Trials Group

Autor: Allan B. MacLean, CR Lewis, Stan B. Kaye, Derek Cruickshank, S. M. Crawford, J. Kennedy, David E. Parkin, James Paul, Henry C Kitchener, T. K. Sarkar, N. S. Reed, H.K. Gordon, M. Soukop, R. Atkinson, R P Symonds, Jim Cassidy, I. D. Duncan, E M Rankin, J. Davis

Publikováno v: Journal of Clinical Oncology. 14:2113-2119

PURPOSE In 1992, we reported the first results of a randomized study in ovarian cancer, comprising two doses of cisplatin and indicated a significant difference (P = .0008) in median survival. Four years later, we now describe the results of this tri

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1628d763798a1d1ca31a365626ede196
https://doi.org/10.1200/jco.1996.14.7.2113